CLOTTAFACT 1.5 g, powder and solvent for solution for injection bottle, 100 ml
Active ingredients: FIBRINOGÈNE HUMAIN
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLOTTAFACT 1,5 g, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 flacon(s) en verre de 100 ml avec dispositif(s) de transfert avec filtre(s) avec matériel(s) de perfusion avec filtre(s)
- Marketing authorisation holder
- LFB-BIOMEDICAMENTS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Nov 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64421453CIP75749719CIP133400957497194Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FIBRINOGÈNE HUMAINpoudre | 1,5 g · 100 ml de solution reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.